Position in TNGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,052,703
+$10,936,362 QoQ
Shares Held
862,940
+7.4% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98.19825248568847.ToString("F0")%
Shared 1.8017475143115396.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. TNGX ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,052,703 | 862,940 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,116,341 | 803,199 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,086,711 | 605,561 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,074,598 | 600,508 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $615,651 | 449,382 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,585,413 | 513,079 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,690,224 | 479,250 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,359,721 | 391,576 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,184,963 | 401,129 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,082,798 | 412,404 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,520,225 | 401,441 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,283,165 | 386,496 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,574,050 | 398,494 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,963,313 | 408,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,508,706 | 416,770 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,973,149 | 435,574 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $921,386 | 121,555 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,362,686 | 124,560 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,463,029 | 113,150 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||